Early antiretroviral therapy in HIV-infected infants: can it lead to HIV remission?
Interventions to prevent mother-to-child HIV transmission have been extremely successful,
but new HIV infections continue to occur in infants. Strong evidence indicates that …
but new HIV infections continue to occur in infants. Strong evidence indicates that …
[HTML][HTML] Factors associated with the development of drug resistance mutations in HIV-1 infected children failing protease inhibitor-based antiretroviral therapy in South …
Objective Limited data are available from the developing world on antiretroviral drug
resistance in HIV-1 infected children failing protease inhibitor-based antiretroviral therapy …
resistance in HIV-1 infected children failing protease inhibitor-based antiretroviral therapy …
[HTML][HTML] Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age
AL Ciaranello, K Doherty, M Penazzato, JC Lindsey… - Aids, 2015 - journals.lww.com
Background: The International Maternal, Pediatric, and Adolescent Clinical Trials P1060 trial
demonstrated superior outcomes for HIV-infected children less than 3 years old initiating …
demonstrated superior outcomes for HIV-infected children less than 3 years old initiating …
Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluation
AN Giralt, C Nöstlinger, J Lee, O Salami, M Lallemant… - BMJ open, 2017 - bmjopen.bmj.com
Background Improving access to paediatric HIV treatment requires both large-scale
treatment programmes and medication that is adapted to infants and children's needs. The …
treatment programmes and medication that is adapted to infants and children's needs. The …
Impact of human immunodeficiency virus drug resistance on treatment of human immunodeficiency virus infection in children in low-and middle-income countries
GK Siberry, A Amzel, A Ramos… - The Journal of …, 2017 - academic.oup.com
Children living with human immunodeficiency virus (HIV) in low-and middle-income
countries (LMICs) experience higher rates of virologic failure than adults. Human …
countries (LMICs) experience higher rates of virologic failure than adults. Human …
HIV-1 drug resistance and second-line treatment in children randomized to switch at low versus higher RNA thresholds
L Harrison, A Melvin, S Fiscus, Y Saidi… - JAIDS Journal of …, 2015 - journals.lww.com
Background: The PENPACT-1 trial compared virologic thresholds to determine when to
switch to second-line antiretroviral therapy (ART). Using PENPACT-1 data, we aimed to …
switch to second-line antiretroviral therapy (ART). Using PENPACT-1 data, we aimed to …
Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluation.
GA Nebot, GA Nebot, C Nöstlinger, J Lee, O Salami… - 2017 - erepository.uonbi.ac.ke
BACKGROUND: Improving access to paediatric HIV treatment requires both large-scale
treatment programmes and medication that is adapted to infants and children's needs. The …
treatment programmes and medication that is adapted to infants and children's needs. The …
[PDF][PDF] growing-up with HIV
D Van der Linden - 2013 - dial.uclouvain.be
This thesis has its origin in my personal background. In 2006, after being trained in the HIV
field by Pr Jack Levy in CHU Saint-Pierre, I worked for nearly 2 years in Pietermaritzburg …
field by Pr Jack Levy in CHU Saint-Pierre, I worked for nearly 2 years in Pietermaritzburg …